Aquisição de Omalizumab 150 mg, Ribociclib 200 mg, Nilotinib 200 mg, Secucinumab 300 mg e Erenumab 70/140 mg ao Hospital de Santo Espírito da Ilha Terceira, E.P.E.R

Contract type	Supplies
CPV	33000000
Awarded to	Novartis Farma - Produtos Farmacêuticos, S.A.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.